Johnson & Johnson increases US investment to over $55 bn over next 4 yrs

Q: How long will it take to read this news story?

The story "Johnson &amp; Johnson increases US investment to over $55 bn over next 4 yrs" has 467 words across 13 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Johnson &amp; Johnson increases US investment to over $55 bn over next 4 yrs" was covered 8 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 182 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #27231434</li><li>URL: https://beamstart.com/news/johnson-johnson-increases-us-investment-1742609465</li></ul>

Business Standard Logo Business Standard 8h ago

Johnson & Johnson increases US investment to over $55 bn over next 4 yrs - Business Standard

Quick Summary:

According to Johnson and Johnson's statement, this represents a 25 per cent increase in investment compared to the previous four years and builds upon the Company's already elevated US investment levels resulting from the passage of the 2017 Tax Cuts & Jobs Act".

Johnson and Johnson, US healthcare's leading, most comprehensive innovation powerhouse, announced on Friday that it will invest more than USD 55 billion in manufacturing, research and development, and technology in the United States over the next four years.

Today's announcements accelerate our nearly 140-year legacy as an American innovation engine tackling the world's toughest healthcare challenges," said Joaquin Duato, Chairman and Chief Executive Officer of Johnson and Johnson.